Intercept Pharmaceuticals
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
SHAPIRO DAVID officer: Chief Medical Officer
 Common Stock 4,000 $10.4 $41,600
Option
SHAPIRO DAVID officer: Chief Medical Officer
 Option to Purchase Common Stock 4,000 $10.4 $41,600
Sale
PRUZANSKI MARK director
 Common Stock 10,000 $8.67 $86,670
Option
PRUZANSKI MARK director
 Option to Purchase Common Stock 10,000 $8.67 $86,670
Option
PRUZANSKI MARK director
 Common Stock 10,000 $8.67 $86,670
Option
SHAPIRO DAVID officer: Chief Medical Officer
 Common Stock 4,000 $10.4 $41,600
Option
FUNDARO PAOLO director, 10 percent owner
 Common Stock 6,922 $9.82 $67,988
Option
SHAPIRO DAVID officer: Chief Medical Officer
 Option to Purchase Common Stock 4,000 $10.4 $41,600
Option
FUNDARO PAOLO director, 10 percent owner
 Option to Purchase Common Stock 3,461 $9.82 $33,994
Sale
SHAPIRO DAVID officer: Chief Medical Officer
 Common Stock 4,743 $276.3 $1,310,500
Option
FUNDARO PAOLO director, 10 percent owner
 Restricted Stock Units 325 N/A N/A
Option
WILLIAMS NICOLE director
 Restricted Stock Units 367 N/A N/A
Option
TALLARIGO LORENZO director
 Common Stock 367 N/A N/A
Option
FUNDARO PAOLO director, 10 percent owner
 Common Stock 325 N/A N/A
Option
SILVERSTEIN JONATHAN director
 Common Stock 325 N/A N/A
Option
VEITINGER KLAUS R DR director
 Common Stock 325 N/A N/A
Option
SILVERSTEIN JONATHAN director
 Restricted Stock Units 325 N/A N/A
Sale
TALLARIGO LORENZO director
 Common Stock 367 N/A N/A
Sale
FUNDARO PAOLO director, 10 percent owner
 Common Stock 325 N/A N/A
Sale
VEITINGER KLAUS R DR director
 Common Stock 162 $230.52 $37,344
Option
TALLARIGO LORENZO director
 Restricted Stock Units 367 N/A N/A
Option
VEITINGER KLAUS R DR director
 Restricted Stock Units 325 N/A N/A
Option
ORBIMED ADVISORS LLC director
 Common Stock, par value $0.001 per share 325 N/A N/A
Option
WILLIAMS NICOLE director
 Common Stock 367 N/A N/A
Option
ORBIMED ADVISORS LLC director
 Common Stock, par value $0.001 per share 1,330 N/A N/A
Option
ADORINI LUCIANO officer: See Remarks
 Option to Purchase Common Stock 2,000 $10.4 $20,800
Sale
TALLARIGO LORENZO director
 Common Stock 1,640 $259.48 $425,547
Option
ADORINI LUCIANO officer: See Remarks
 Common Stock 2,000 $10.4 $20,800
Sale
VEITINGER KLAUS R DR director
 Common Stock 665 $235.05 $156,310
Sale
ADORINI LUCIANO officer: See Remarks
 Common Stock 2,000 $260.76 $521,520
Sale
PRUZANSKI MARK director
 Common Stock 10,000 $8.67 $86,670
Option
PRUZANSKI MARK director
 Common Stock 10,000 $8.67 $86,670
Option
PRUZANSKI MARK director
 Option to Purchase Common Stock 10,000 $8.67 $86,670
Option
AKKARAJU SRINIVAS director
 Restricted Stock Units 324 N/A N/A
Option
PRUZANSKI MARK director
 Option to Purchase Common Stock 10,000 $242.22 $2,422,170
Sale
PRUZANSKI MARK director
 Common Stock 10,000 $242.22 $2,422,170
Option
PRUZANSKI MARK director
 Common Stock 10,000 $242.22 $2,422,170
Option
AKKARAJU SRINIVAS director
 Common Stock 324 N/A N/A
Option
PRUZANSKI MARK director
 Option to Purchase Common Stock 30,309 $6.74 $204,313
Option
PRUZANSKI MARK director
 Common Stock 30,309 $6.74 $204,313
Sale
DUNCAN BARBARA GAYLE officer: Chief Accounting Officer
 Common Stock 1,154 $279 $321,966
Option
DUNCAN BARBARA GAYLE officer: Chief Accounting Officer
 Common Stock 1,154 $279 $321,966
Option
DUNCAN BARBARA GAYLE officer: Chief Accounting Officer
 Option to Purchase Common Stock 1,154 $279 $321,966
Sale
TALLARIGO LORENZO director
 Common Stock 30,623 $293.91 $9,000,406
Sale
MICHELI FRANCESCO 10 percent owner
 Common Stock 30,623 $293.91 $9,000,406
Sale
GENEXTRA S.P.A. 10 percent owner
 Common Stock 30,623 $293.91 $9,000,406
Sale
TALLARIGO LORENZO director
 Common Stock 318,695 $320 $101,982,400
Sale
ORBIMED ADVISORS LLC director
 Common Stock, par value $0.001 per share 81,305 $320 $26,017,600
Sale
GENEXTRA S.P.A. 10 percent owner
 Common Stock 318,695 $320 $101,982,400
Sale
SILVERSTEIN JONATHAN director
 Common Stock 81,305 $320 $26,017,600

Showing 550 to 600 of 875 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: